Sangamo BioSciences Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Janney Montgomery Scott Downgrades Sangamo BioSciences (SGMO) to Neutral
August 4, 2016 7:25 AM EDTJanney Montgomery Scott downgraded Sangamo BioSciences (NASDAQ: SGMO) from Buy to Neutral with a price target of $8.00 (from $15.00).
For an analyst ratings summary and ratings history on Sangamo BioSciences click here. For more ratings news on Sangamo BioSciences click here.
Shares of Sangamo BioSciences closed at $6.84 yesterday.
... MoreSangamo Biosciences (SGMO) Misses Q2 EPS by 14c
August 3, 2016 4:36 PM EDTSangamo Biosciences (NASDAQ: SGMO) reported Q2 EPS of ($0.38), $0.14 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $5.38 million.
Financial Guidance for 2016 The Company updates guidance as follows:
Cash and Investments: Sangamo... More